RSS-Feed abonnieren
DOI: 10.1055/s-0045-1811965
Reproductive History and Cardio-Metabolic Risk in the Postmenopausal Age
Authors
Funding None.

Abstract
Menopause represents a cardio-metabolic transition, but cardiovascular (CV) health in women is highly influenced by other reproductive milestones and conditions, which delineate a cardio-reproductive lifeline. Reproductive history represents an opportunity to identify women at elevated risk of CV events after menopause, going beyond traditional CV risk factors. This review aims to summarize the impact of reproductive milestones, gynecological conditions, and pregnancy-related factors on cardio-metabolic health at midlife. The main physio-pathological mechanisms likely implicated in linking reproductive events and CV disease risk are described, as well as the impact of specific conditions (early/late menarche and menstrual dysfunction [functional hypothalamic amenorrhea, polycystic ovary syndrome, benign gynecological conditions (endometriosis, adenomyosis, and fibroids), infertility, adverse pregnancy outcomes, and premature/early natural or surgical menopause]). Data indicate that a reproductive checklist in midlife women is warranted for primary prevention and intervention.
Keywords
menopause - cardiovascular disease - reproductive history - adverse pregnancy outcomes - menstrual dysfunctionAuthors' Contributions
All authors participated in writing the manuscript and have seen and approved the submitted version.
Publikationsverlauf
Artikel online veröffentlicht:
30. September 2025
© 2025. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Lobo RA, Gompel A. Management of menopause: a view towards prevention. Lancet Diabetes Endocrinol 2022; 10 (06) 457-470
- 2 Martin SS, Aday AW, Almarzooq ZI. et al; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. 2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association. Circulation 2024; 149 (08) e347-e913
- 3 El Khoudary SR, Aggarwal B, Beckie TM. et al; American Heart Association Prevention Science Committee of the Council on Epidemiology and Prevention; and Council on Cardiovascular and Stroke Nursing. Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American Heart Association. Circulation 2020; 142 (25) e506-e532
- 4 Vogel B, Acevedo M, Appelman Y. et al. The Lancet women and cardiovascular disease commission: reducing the global burden by 2030. Lancet 2021; 397 (10292): 2385-2438
- 5 Shaw LJ, Pepine CJ, Xie J. et al. Quality and equitable health care gaps for women: attributions to sex differences in cardiovascular medicine. J Am Coll Cardiol 2017; 70 (03) 373-388
- 6 Nappi RE, Chedraui P, Lambrinoudaki I, Simoncini T. Menopause: a cardiometabolic transition. Lancet Diabetes Endocrinol 2022; 10 (06) 442-456
- 7 Uddenberg ER, Safwan N, Saadedine M, Hurtado MD, Faubion SS, Shufelt CL. Menopause transition and cardiovascular disease risk. Maturitas 2024; 185: 107974
- 8 Sowers M, Zheng H, Tomey K. et al. Changes in body composition in women over six years at midlife: ovarian and chronological aging. J Clin Endocrinol Metab 2007; 92 (03) 895-901
- 9 Matthews KA, Crawford SL, Chae CU. et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition?. J Am Coll Cardiol 2009; 54 (25) 2366-2373
- 10 Kalyani RR, Franco M, Dobs AS. et al. The association of endogenous sex hormones, adiposity, and insulin resistance with incident diabetes in postmenopausal women. J Clin Endocrinol Metab 2009; 94 (11) 4127-4135
- 11 Samargandy S, Matthews KA, Brooks MM. et al. Arterial stiffness accelerates within 1 year of the final menstrual period: the SWAN Heart Study. Arterioscler Thromb Vasc Biol 2020; 40 (04) 1001-1008
- 12 Moreau KL, Hildreth KL, Meditz AL, Deane KD, Kohrt WM. Endothelial function is impaired across the stages of the menopause transition in healthy women. J Clin Endocrinol Metab 2012; 97 (12) 4692-4700
- 13 Samargandy S, Matthews KA, Brooks MM. et al. Trajectories of blood pressure in midlife women: does menopause matter?. Circ Res 2022; 130 (03) 312-322
- 14 O'Kelly AC, Michos ED, Shufelt CL. et al. Pregnancy and reproductive risk factors for cardiovascular disease in women. Circ Res 2022; 130 (04) 652-672
- 15 Bushnell C, Kernan WN, Sharrief AZ. et al. 2024 guideline for the primary prevention of stroke: a guideline from the American Heart Association/American Stroke Association. Stroke 2024; 55 (12) e344-e424
- 16 Ley SH, Li Y, Tobias DK. et al. Duration of reproductive life span, age at menarche, and age at menopause are associated with risk of cardiovascular disease in women. J Am Heart Assoc 2017; 6 (11) e006713
- 17 Molinelli C, Jacobs F, Nader-Marta G. et al. Ovarian suppression: early menopause and late effects. Curr Treat Options Oncol 2024; 25 (04) 523-542
- 18 Helvaci N, Yildiz BO. Polycystic ovary syndrome as a metabolic disease. Nat Rev Endocrinol 2025; 21 (04) 230-244
- 19 Hirschberg AL. Hyperandrogenism and cardiometabolic risk in pre- and postmenopausal women-what is the evidence?. J Clin Endocrinol Metab 2024; 109 (05) 1202-1213
- 20 Plu-Bureau G, Hugon-Rodin J, Maitrot-Mantelet L, Canonico M. Hormonal contraceptives and arterial disease: an epidemiological update. Best Pract Res Clin Endocrinol Metab 2013; 27 (01) 35-45
- 21 Dou W, Huang Y, Liu X. et al. Associations of oral contraceptive use with cardiovascular disease and all-cause death: evidence from the UK Biobank cohort study. J Am Heart Assoc 2023; 12 (16) e030105
- 22 Franceschi C, Bonafè M, Valensin S. et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000; 908: 244-254
- 23 Aranda JF, Ramírez CM, Mittelbrunn M. Inflammaging, a targetable pathway for preventing cardiovascular diseases. Cardiovasc Res 2024; 12: cvae240
- 24 Zavatta A, Parisi F, Mandò C, Scaccabarozzi C, Savasi VM, Cetin I. Role of inflammaging on the reproductive function and pregnancy. Clin Rev Allergy Immunol 2023; 64 (02) 145-160
- 25 AlAshqar A, Reschke L, Kirschen GW, Borahay MA. Role of inflammation in benign gynecologic disorders: from pathogenesis to novel therapies. Biol Reprod 2021; 105 (01) 7-31
- 26 Aboeldalyl S, James C, Seyam E, Ibrahim EM, Shawki HE, Amer S. The role of chronic inflammation in polycystic ovarian syndrome-a systematic review and meta-analysis. Int J Mol Sci 2021; 22 (05) 2734
- 27 Teede HJ, Tay CT, Laven JJE. et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. J Clin Endocrinol Metab 2023; 108 (10) 2447-2469
- 28 Vercellini P, Viganò P, Bandini V, Buggio L, Berlanda N, Somigliana E. Association of endometriosis and adenomyosis with pregnancy and infertility. Fertil Steril 2023; 119 (05) 727-740
- 29 Romero R, Gotsch F, Pineles B, Kusanovic JP. Inflammation in pregnancy: its roles in reproductive physiology, obstetrical complications, and fetal injury. Nutr Rev 2007; 65 (12 Pt 2): S194-S202
- 30 Li W, Liu Q, Deng X, Chen Y, Liu S, Story M. Association between obesity and puberty timing: a systematic review and meta-analysis. Int J Environ Res Public Health 2017; 14 (10) 1266
- 31 Qin H, Lin Z, Vásquez E, Luan X, Guo F, Xu L. Association between obesity and the risk of uterine fibroids: a systematic review and meta-analysis. J Epidemiol Community Health 2021; 75 (02) 197-204
- 32 Zheng L, Yang L, Guo Z, Yao N, Zhang S, Pu P. Obesity and its impact on female reproductive health: unraveling the connections. Front Endocrinol (Lausanne) 2024; 14: 1326546
- 33 Lane-Cordova AD, Khan SS, Grobman WA, Greenland P, Shah SJ. Long-term cardiovascular risks associated with adverse pregnancy outcomes: JACC review topic of the week. J Am Coll Cardiol 2019; 73 (16) 2106-2116
- 34 Mantel Ä, Wollmann CL, Faxén J, Sandström A, Mühlrad H, Stephansson O. Adverse pregnancy outcomes, familial predisposition, and cardiovascular risk: a Swedish nationwide study. Eur Heart J 2025; 46 (08) 733-745
- 35 Tyrmi JS, Kaartokallio T, Lokki AI. et al; FINNPEC Study Group, FinnGen Project, and the Estonian Biobank Research Team. Genetic risk factors associated with preeclampsia and hypertensive disorders of pregnancy. JAMA Cardiol 2023; 8 (07) 674-683
- 36 Trikudanathan S, Pedley A, Massaro JM. et al. Association of female reproductive factors with body composition: the Framingham Heart Study. J Clin Endocrinol Metab 2013; 98 (01) 236-244
- 37 Gill D, Brewer CF, Del Greco M F. et al. Age at menarche and adult body mass index: a Mendelian randomization study. Int J Obes (Lond) 2018; 42 (09) 1574-1581
- 38 Gaml-Sørensen A, Brix N, Ernst A. et al. Pubertal timing and tempo and body mass index trajectories: investigating the confounding role of childhood body mass index. Am J Epidemiol 2025; 194 (08) 2270-2280
- 39 Cheng TS, Day FR, Lakshman R, Ong KK. Association of puberty timing with type 2 diabetes: a systematic review and meta-analysis. PLoS Med 2020; 17 (01) e1003017
- 40 Dreyfus J, Jacobs Jr DR, Mueller N. et al. Age at menarche and cardiometabolic risk in adulthood: the coronary artery risk development in young adults study. J Pediatr 2015; 167 (02) 344-52.e1
- 41 Kwan BS, Yang J, Jo HC, Baek JC, Kim RB, Park JE. Age at menarche and its association with adult-onset metabolic syndrome and related disorders in women: a cross-sectional study of a nationally representative sample over 10 years. Asia Pac J Public Health 2024; 36 (6–7): 558-564
- 42 Martinho LCAP, Zaniqueli D, Andreazzi AE, Oliveira CM, Pereira AC, Alvim RO. Association between early menarche and hypertension in pre and postmenopausal women: Baependi Heart Study. J Hypertens 2025; 43 (02) 318-324
- 43 Mishra SR, Chung HF, Waller M. et al. Association between reproductive life span and incident nonfatal cardiovascular disease: a pooled analysis of individual patient data from 12 studies. JAMA Cardiol 2020; 5 (12) 1410-1418
- 44 Behboudi-Gandevan S, Moe CF, Skjesol I, Arntzen EC, Bidhendi-Yarandi R. The J shaped association of age at menarche and cardiovascular events: systematic review and meta-analysis. Sci Rep 2024; 14 (01) 2695
- 45 Tschiderer L, Peters SAE, van der Schouw YT. et al. Reassessing the association between age at menarche and cardiovascular disease: observational and Mendelian randomization analyses. Eur J Prev Cardiol 2025; 18: zwaf051
- 46 Dastmalchi LN, Gulati M. Age at menarche and cardiovascular risk: a moving target of risk assessment in women. Eur J Prev Cardiol 2025; 5: zwaf318
- 47 Cooper R, Blell M, Hardy R. et al. Validity of age at menarche self-reported in adulthood. J Epidemiol Community Health 2006; 60 (11) 993-997
- 48 Eckert-Lind C, Busch AS, Petersen JH. et al. Worldwide secular trends in age at pubertal onset assessed by breast development among girls: a systematic review and meta-analysis. JAMA Pediatr 2020; 174 (04) e195881
- 49 Keenan K, Hipwell AE, Polonsky TS. Menstrual cycle irregularity in adolescence is associated with cardiometabolic health in early adulthood. J Am Heart Assoc 2023; 12 (18) e029372
- 50 Wang Z, Jukic AMZ, Baird DD. et al. Irregular cycles, ovulatory disorders, and cardiometabolic conditions in a US-based digital cohort. JAMA Netw Open 2024; 7 (05) e249657
- 51 Wang YX, Stuart JJ, Rich-Edwards JW. et al. Menstrual cycle regularity and length across the reproductive lifespan and risk of cardiovascular disease. JAMA Netw Open 2022; 5 (10) e2238513
- 52 Huang C, Lin B, Yuan Y. et al. Associations of menstrual cycle regularity and length with cardiovascular diseases: a prospective study from UK Biobank. J Am Heart Assoc 2023; 12 (11) e029020
- 53 Naveed A, Whooten R. Time to cycle regularity and health risks. Curr Opin Endocrinol Diabetes Obes 2024; 31 (06) 210-215
- 54 ACOG Committee Opinion No. ACOG committee opinion no. 651: menstruation in girls and adolescents: using the menstrual cycle as a vital sign. Obstet Gynecol 2015; 126 (06) e143-e146
- 55 Zeni Hoch A, Dempsey RL, Carrera GF. et al. Is there an association between athletic amenorrhea and endothelial cell dysfunction?. Med Sci Sports Exerc 2003; 35 (03) 377-383
- 56 Rickenlund A, Eriksson MJ, Schenck-Gustafsson K, Hirschberg AL. Amenorrhea in female athletes is associated with endothelial dysfunction and unfavorable lipid profile. J Clin Endocrinol Metab 2005; 90 (03) 1354-1359
- 57 Shufelt CL, Saadedine M, Cook-Wiens G. et al. Functional hypothalamic amenorrhea and preclinical cardiovascular disease. J Clin Endocrinol Metab 2023; 109 (01) e51-e57
- 58 Bairey Merz CN, Johnson BD, Sharaf BL. et al; WISE Study Group. Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study. J Am Coll Cardiol 2003; 41 (03) 413-419
- 59 Ahmed B, Bairey Merz CN, Johnson BD. et al; WISE Study Group. Diabetes mellitus, hypothalamic hypoestrogenemia, and coronary artery disease in premenopausal women (from the National Heart, Lung, and Blood Institute sponsored WISE study). Am J Cardiol 2008; 102 (02) 150-154
- 60 O'Donnell E, Goodman JM, Harvey PJ. Clinical review: cardiovascular consequences of ovarian disruption: a focus on functional hypothalamic amenorrhea in physically active women. J Clin Endocrinol Metab 2011; 96 (12) 3638-3648
- 61 Shufelt CL, Safwan N, Saadedine M. et al. Impact of estrogen replacement on endothelial dysfunction and psychological health in women with hypothalamic amenorrhea. J Clin Endocrinol Metab 2025; dgaf364
- 62 Shufelt CL, Torbati T, Dutra E. Hypothalamic amenorrhea and the long-term health consequences. Semin Reprod Med 2017; 35 (03) 256-262
- 63 Ramezani Tehrani F, Amiri M, Behboudi-Gandevani S, Bidhendi-Yarandi R, Carmina E. Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: a systematic review and meta-analysis. Gynecol Endocrinol 2020; 36 (01) 12-23
- 64 Millán-de-Meer M, Luque-Ramírez M, Nattero-Chávez L, Escobar-Morreale HF. PCOS during the menopausal transition and after menopause: a systematic review and meta-analysis. Hum Reprod Update 2023; 29 (06) 741-772
- 65 Helvaci N, Yildiz BO. Polycystic ovary syndrome and aging: health implications after menopause. Maturitas 2020; 139: 12-19
- 66 Luo X, Wang Y, Wang L, Shen Y, Ren M. Association between female androgen levels, metabolic syndrome, and cardiovascular disease: an NHANES analysis (2013-2016). Int J Womens Health 2024; 16: 2087-2101
- 67 Velez LM, Seldin M, Motta AB. Inflammation and reproductive function in women with polycystic ovary syndrome. Biol Reprod 2021; 104 (06) 1205-1217
- 68 Gao L, Zhao Y, Wu H. et al. Polycystic ovary syndrome fuels cardiovascular inflammation and aggravates ischemic cardiac injury. Circulation 2023; 148 (24) 1958-1973
- 69 AlAshqar A, Patzkowsky K, Afrin S, Wild R, Taylor HS, Borahay MA. Cardiometabolic risk factors and benign gynecologic disorders. Obstet Gynecol Surv 2019; 74 (11) 661-673
- 70 Colombo GE, Mahamat-Saleh Y, Armour M. et al. Non-malignant gynaecological disease and risk of cardiovascular or cerebrovascular disease: a systematic review and meta-analysis. Heart 2025; 111 (09) 402-411
- 71 Ingelsson E, Lundholm C, Johansson AL, Altman D. Hysterectomy and risk of cardiovascular disease: a population-based cohort study. Eur Heart J 2011; 32 (06) 745-750
- 72 Henry J, Berrandou T, Brewster LM, Bouatia-Naji N. Blood pressure, cardiometabolic traits, and cardiovascular events in women with uterine fibroids: a genetic correlation and Mendelian randomization study. J Am Heart Assoc 2025; 14 (08) e036697
- 73 Cui J, Zhao YC, She LZ, Wang TJ. Causal relationship between uterine fibroids and cardiovascular disease: a two-sample Mendelian randomization study. Medicine (Baltimore) 2025; 104 (09) e41713
- 74 Yao M, Zhao S, Zhang D, Cui Y, Wang Y, Jiang L. Causal association between uterine fibroids and cardiovascular disease: a Mendelian randomization study. Medicine (Baltimore) 2025; 104 (22) e42627
- 75 Dubey P, Reddy S, Singh V, Yousif A, Dwivedi AK. Association of heavy menstrual bleeding with cardiovascular disease in US female hospitalizations. BMC Med 2024; 22 (01) 208
- 76 Mu F, Rich-Edwards J, Rimm EB, Spiegelman D, Forman JP, Missmer SA. Association Between Endometriosis and Hypercholesterolemia or Hypertension. Hypertension 2017; 70 (01) 59-65
- 77 Mu F, Rich-Edwards J, Rimm EB, Spiegelman D, Missmer SA. Endometriosis and risk of coronary heart disease. Circ Cardiovasc Qual Outcomes 2016; 9 (03) 257-264
- 78 Parsa S, Noroozpoor R, Dehghanbanadaki H, Khateri S, Moradi Y. Endometriosis and risk of cardiovascular disease: a systematic review and meta-analysis. BMC Public Health 2025; 25 (01) 245
- 79 Poeta do Couto C, Policiano C, Pinto FJ, Brito D, Caldeira D. Endometriosis and cardiovascular disease: a systematic review and meta-analysis. Maturitas 2023; 171: 45-52
- 80 Okoli U, Charoenngam N, Ponvilawan B, Jaroenlapnopparat A, Mettler S, Obiejesie O. Endometriosis and risk of cardiovascular disease: systematic review and meta-analysis. J Womens Health (Larchmt) 2023; 32 (12) 1328-1339
- 81 Farland LV, Wang YX, Gaskins AJ. et al. Infertility and risk of cardiovascular disease: a prospective cohort study. J Am Heart Assoc 2023; 12 (05) e027755
- 82 Magnus MC, Fraser A, Rich-Edwards JW, Magnus P, Lawlor DA, Håberg SE. Time-to-pregnancy and risk of cardiovascular disease among men and women. Eur J Epidemiol 2021; 36 (04) 383-391
- 83 Verit FF, Yildiz Zeyrek F, Zebitay AG, Akyol H. Cardiovascular risk may be increased in women with unexplained infertility. Clin Exp Reprod Med 2017; 44 (01) 28-32
- 84 Parikh NI, Gonzalez JM, Anderson CAM. et al; American Heart Association Council on Epidemiology and Prevention; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; and the Stroke Council. Adverse pregnancy outcomes and cardiovascular disease risk: unique opportunities for cardiovascular disease prevention in women: a scientific statement from the American Heart Association. Circulation 2021; 143 (18) e902-e916
- 85 Kyriacou H, Al-Mohammad A, Muehlschlegel C. et al. The risk of cardiovascular diseases after miscarriage, stillbirth, and induced abortion: a systematic review and meta-analysis. Eur Heart J Open 2022; 2 (05) oeac065
- 86 Liu X, Chen Y, Ye C. et al. Hereditary thrombophilia and recurrent pregnancy loss: a systematic review and meta-analysis. Hum Reprod 2021; 36 (05) 1213-1229
- 87 Delis M, Emmanouilidou-Fotoulaki E, Chatzakis C, Theodoridis T, Sotiriadis A. Inherited thrombophilias and stillbirth: a systematic review and meta- analysis. Arch Gynecol Obstet 2025; 312 (01) 37-50
- 88 Mauricio R, Sharma G, Lewey J. et al; American Heart Association Cardiovascular Disease and Stroke in Women and Underrepresented Populations Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and Council on Lifelong Congenital Heart Disease and Heart Health in the Young. Assessing and addressing cardiovascular and obstetric risks in patients undergoing assisted reproductive technology: a scientific statement from the American Heart Association. Circulation 2025; 151 (08) e661-e676
- 89 Dayan N, Filion KB, Okano M. et al. Cardiovascular risk following fertility therapy: systematic review and meta-analysis. J Am Coll Cardiol 2017; 70 (10) 1203-1213
- 90 Magnus MC, Fraser A, Håberg SE. et al. Maternal risk of cardiovascular disease after use of assisted reproductive technologies. JAMA Cardiol 2023; 8 (09) 837-845
- 91 Udell JA, Lu H, Redelmeier DA. Failure of fertility therapy and subsequent adverse cardiovascular events. CMAJ 2017; 189 (10) E391-E397
- 92 Parikh NI, Cnattingius S, Dickman PW, Mittleman MA, Ludvigsson JF, Ingelsson E. Parity and risk of later-life maternal cardiovascular disease. Am Heart J 2010; 159 (02) 215-221.e6
- 93 Lawlor DA, Emberson JR, Ebrahim S. et al; British Women's Heart and Health Study, British Regional Heart Study. Is the association between parity and coronary heart disease due to biological effects of pregnancy or adverse lifestyle risk factors associated with child-rearing? Findings from the British Women's Heart and Health Study and the British Regional Heart Study. Circulation 2003; 107 (09) 1260-1264
- 94 Chen T, Wu J, Pan Q, Dong M. The association of female reproductive factors with history of cardiovascular disease: a large cross-sectional study. BMC Public Health 2024; 24 (01) 1616
- 95 Dassanayake M, Langen E, Davis MB. Pregnancy complications as a window to future cardiovascular disease. Cardiol Rev 2020; 28 (01) 14-19
- 96 Crump C, Sundquist J, Sundquist K. Adverse pregnancy outcomes and long-term mortality in women. JAMA Intern Med 2024; 184 (06) 631-640
- 97 Osei-Safo EK, McIntosh J, Onwuka S. et al. What is my risk? A mixed-methods systematic review of risk perception for cardiometabolic pregnancy complications and future cardiometabolic disease development. Obes Rev 2025; e13967
- 98 Sukmanee J, Liabsuetrakul T. Risk of future cardiovascular diseases in different years postpartum after hypertensive disorders of pregnancy: a systematic review and meta-analysis. Medicine (Baltimore) 2022; 101 (30) e29646
- 99 Morooka H, Haug EB, Malmo V. et al. Adverse pregnancy outcomes and risk of atrial fibrillation: findings from the HUNT study. Eur J Prev Cardiol 2025; zwaf233
- 100 Melchiorre K, Thilaganathan B, Giorgione V, Ridder A, Memmo A, Khalil A. Hypertensive disorders of pregnancy and future cardiovascular health. Front Cardiovasc Med 2020; 7: 59
- 101 Dall'Asta A, D'Antonio F, Saccone G. et al. Cardiovascular events following pregnancy complicated by pre-eclampsia with emphasis on comparison between early- and late-onset forms: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2021; 57 (05) 698-709
- 102 Palmiero P, Caretto P, Ciccone MM, Maiello M. On Behalf Of The I C I S C U Italian Chapter Of International Society Cardiovascular Ultrasound. Long-term cardiovascular risk and maternal history of pre-eclampsia. J Clin Med 2025; 14 (09) 3121
- 103 Stuart JJ, Tanz LJ, Rimm EB. et al. Cardiovascular risk factors mediate the long-term maternal risk associated with hypertensive disorders of pregnancy. J Am Coll Cardiol 2022; 79 (19) 1901-1913
- 104 Vounzoulaki E, Khunti K, Abner SC, Tan BK, Davies MJ, Gillies CL. Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis. BMJ 2020; 369: m1361
- 105 Chen A, Tan B, Du R. et al. Gestational diabetes mellitus and development of intergenerational overall and subtypes of cardiovascular diseases: a systematic review and meta-analysis. Cardiovasc Diabetol 2024; 23 (01) 320
- 106 Cameron NA, Petito LC, Colangelo LA. et al. Prepregnancy cardiovascular health, gestational diabetes, and coronary artery calcium. JAMA Cardiol 2025; e251887
- 107 Grandi SM, Filion KB, Yoon S. et al. Cardiovascular disease-related morbidity and mortality in women with a history of pregnancy complications. Circulation 2019; 139 (08) 1069-1079
- 108 Crump C, Sundquist J, McLaughlin MA. et al. Adverse pregnancy outcomes and long term risk of ischemic heart disease in mothers: national cohort and co-sibling study. BMJ 2023; 380: e072112
- 109 Sławek-Szmyt S, Kawka-Paciorkowska K, Ciepłucha A, Lesiak M, Ropacka-Lesiak M. Preeclampsia and fetal growth restriction as risk factors of future maternal cardiovascular disease-a review. J Clin Med 2022; 11 (20) 6048
- 110 Staff AC, Redman CW, Williams D. et al; Global Pregnancy Collaboration (CoLab). Pregnancy and long-term maternal cardiovascular health: progress through harmonization of research cohorts and biobanks. Hypertension 2016; 67 (02) 251-260
- 111 Haug EB, Markovitz AR, Fraser A. et al. The role of cardiovascular risk factors in maternal cardiovascular disease according to offspring birth characteristics in the HUNT study. Sci Rep 2021; 11 (01) 22981
- 112 Wu P, Gulati M, Kwok CS. et al. Preterm delivery and future risk of maternal cardiovascular disease: a systematic review and meta-analysis. J Am Heart Assoc 2018; 7 (02) e007809
- 113 Auger N, Potter BJ, He S, Healy-Profitós J, Schnitzer ME, Paradis G. Maternal cardiovascular disease 3 decades after preterm birth: longitudinal cohort study of pregnancy vascular disorders. Hypertension 2020; 75 (03) 788-795
- 114 Rohlfing AB, Nah G, Ryckman KK. et al. Maternal cardiovascular disease risk factors as predictors of preterm birth in California: a case-control study. BMJ Open 2020; 10 (06) e034145
- 115 Zhu D, Chung HF, Dobson AJ. et al. Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data. Lancet Public Health 2019; 4 (11) e553-e564
- 116 Zhu D, Chung HF, Dobson AJ. et al. Type of menopause, age of menopause and variations in the risk of incident cardiovascular disease: pooled analysis of individual data from 10 international studies. Hum Reprod 2020; 35 (08) 1933-1943
- 117 Honigberg MC, Zekavat SM, Aragam K. et al. Association of premature natural and surgical menopause with incident cardiovascular disease. JAMA 2019; 322 (24) 2411-2421
- 118 Thurston RC, Aslanidou Vlachos HE, Derby CA. et al. Menopausal vasomotor symptoms and risk of incident cardiovascular disease events in SWAN. J Am Heart Assoc 2021; 10 (03) e017416
- 119 Armeni A, Anagnostis P, Armeni E, Mili N, Goulis D, Lambrinoudaki I. Vasomotor symptoms and risk of cardiovascular disease in peri- and postmenopausal women: a systematic review and meta-analysis. Maturitas 2023; 171: 13-20
- 120 Bahri Khomami M, Shorakae S, Hashemi S. et al. Systematic review and meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Nat Commun 2024; 15 (01) 5591
- 121 Lu MY, Niu JL, Liu B. The risk of endometriosis by early menarche is recently increased: a meta-analysis of literature published from 2000 to 2020. Arch Gynecol Obstet 2023; 307 (01) 59-69
- 122 Horton J, Sterrenburg M, Lane S, Maheshwari A, Li TC, Cheong Y. Reproductive, obstetric, and perinatal outcomes of women with adenomyosis and endometriosis: a systematic review and meta-analysis. Hum Reprod Update 2019; 25 (05) 592-632
- 123 Doust J, Baneshi MR, Chung HF, Wilson LF, Mishra GD. Assessing the accuracy of cardiovascular disease prediction using female-specific risk factors in women aged 45 to 69 years in the UK Biobank study. Circ Cardiovasc Qual Outcomes 2024; 17 (12) e010842
- 124 Maas AHEM, Rosano G, Cifkova R. et al. Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists. Eur Heart J 2021; 42 (10) 967-984
- 125 Arnett DK, Blumenthal RS, Albert MA. et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation 2019; 140 (11) e563-e595
- 126 Halmer S, Fohleitner S, Jutz F. et al. Healthcare providers' awareness and management of cardiovascular risks in women with hypertensive disorders of pregnancy and gestational diabetes. Arch Gynecol Obstet 2025; 312 (02) 413-423